InvestorsHub Logo

BioBS2012

09/02/14 9:13 AM

#188476 RE: cheynew #188475

Must have been added late last night or this morning.

Only Dimitri (KOL) is on the Agenda - as far as anyone directly associated with PPHM.

Abstracts were due August 15 and notification is on Spetember 8 (Monday).

Highlights from the Poster Session

Of the accepted posters, a select few will also be invited to deliver a lecture during the meeting's general session.




EDIT:
https://www.regonline.com/builder/site/tab3.aspx?EventID=1477794

EYEBUYSTOX

09/02/14 11:10 AM

#188488 RE: cheynew #188475

CRI in October

I was poking around their site last week and found the satellite symposium of particular interest considering the "new" MOA of bavituximab, the addition of "additional blood and plasma tests" to the phase 2 portion of the sorafenib IST and the discussion of apoptotic CTCs in the breast IST:

New to the meeting this year, we will be hosting a special Cancer Immunotherapy Consortium (CIC) satellite meeting on October 5 entitled Development of Surrogate Endpoints for Cancer Immunotherapy Trials. - See more at: http://www.cancerresearch.org/grants-programs/conferences-meetings/annual-international-cancer-immunotherapy-symposia/2014-symposium#sthash.xY23G9Qo.dpuf